InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Krasner Alan Seth, Directeur Médical. Insider active across 1 company, notably Crinetics Pharmaceuticals, Inc.. Aggregated, 5 filings have been published. History available since 19 January 2022. The latest transaction was filed on 17 October 2023 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Krasner Alan Seth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
7,000 股@ US$12.0132.0% 占其流量Common StockSEC:0001209191-23-053186:0
1,687 股@ US$17.1211.0% 占其流量Common StockSEC:0001209191-23-019770:0
19,500 股0Common StockSEC:0001209191-23-015598:0
14,250 股0Common StockSEC:0001209191-22-015129:0
6,700 股@ US$12.0139.9% 占其流量Common StockSEC:0001209191-22-004453:0
5 条申报中的 5 条
About Krasner Alan Seth
Alan Seth Krasner is the Chief Medical Officer at Crinetics Pharmaceuticals, Inc. He is responsible for medical leadership and product development strategies. His role is essential in ensuring that Crinetics' products meet safety and efficacy standards.
